Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial

BACKGROUND: No standard treatment is available for advanced biliary tract cancer (BTC) after first-line therapy with gemcitabine plus cisplatin (GEMCIS). The objective of this study was to evaluate safety and anti-tumour activity of fluorouracil, leucovorin, irinotecan plus oxaliplatin (FOLFIRINOX)...

Descripción completa

Detalles Bibliográficos
Autores principales: Belkouz, Ali, de Vos-Geelen, Judith, Mathôt, Ron A. A., Eskens, Ferry A. L. M., van Gulik, Thomas M., van Oijen, Martijn G. H., Punt, Cornelis J. A., Wilmink, Johanna W., Klümpen, Heinz-Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054309/
https://www.ncbi.nlm.nih.gov/pubmed/31919404
http://dx.doi.org/10.1038/s41416-019-0698-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054309/
https://www.ncbi.nlm.nih.gov/pubmed/31919404
http://dx.doi.org/10.1038/s41416-019-0698-9

Ejemplares similares